(-)-SKF-10,047 (CHEBI:228224)

ChEBI > Main

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name	(−)-SKF-10,047

ChEBI ID	CHEBI:228224

ChEBI ASCII Name	(-)-SKF-10,047

Definition	The (−)-stereoisomer of SKF-10,047.

Stars	This entity has been manually annotated by the ChEBI Team.

Supplier Information

Download	Molfile XML SDF

Formula

C17H23NO

Net Charge

Average Mass

257.377

Monoisotopic Mass

257.17796

InChI

InChI=1S/C17H23NO/c1-4-8-18-9-7-17(3)12(2)16(18)10-13-5-6-14(19)11-15(13)17/h4-6,11-12,16,19H,1,7-10H2,2-3H3/t12-,16+,17+/m0/s1

InChIKey

LGQCVMYAEFTEFN-JCURWCKSSA-N

SMILES

C[C@H]1[C@H]2CC3=C(C=C(O)C=C3)[C@]1(C)CCN2CC=C

Roles Classification
Chemical Role(s):	Bronsted base A molecular entity capable of accepting a hydron from a donor (Bronsted acid). (via organic amino compound )

Biological Role(s):	opioid analgesic A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood. (via SKF-10,047 ) opioid receptor antagonist An agent that binds to but does not activate an opioid receptor thereby blocking the actions of endogenous or exogenous opioid receptor agonists. (via SKF-10,047 )

Application(s):	opioid analgesic A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood. (via SKF-10,047 ) opioid receptor antagonist An agent that binds to but does not activate an opioid receptor thereby blocking the actions of endogenous or exogenous opioid receptor agonists. (via SKF-10,047 )

IUPAC Name

(2R,6R,11R)-6,11-dimethyl-3-(prop-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol

Synonyms	Sources
(−)-alazocine	ChEBI
(−)-N-allylnormetazocine	ChEBI
(−)-NANM	ChEBI
(−)-SKF 10047	ChEBI
(−)-SKF-10047	ChEBI
(−)SKF 10,047	ChEBI
(2R,6R,11R)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol	ChEBI
l-N-allylnormetazocine	ChEBI
l-SKF 10047	ChEBI

Registry Number	Type	Source
14198-28-8	CAS Registry Number	ChEBI

Last Modified

17 November 2023